MESO Mesoblast Limited

5.47
+0.01  (0%)
Previous Close 5.46
Open 5.40
Price To book 0.92
Market Cap 473222193
Shares 86,512,284
Volume 5,302
Short Ratio 9.78
Av. Daily Volume 25,998

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data due 1Q 2018.
MPC-150-IM
Chronic heart failure (CHF)
Ongoing
MPC-06-ID
Chronic low back pain
Phase 3 data due 2H 2017.
MSC-100-IV
acute graft versus host disease (aGVHD) in children
Phase 2 data released August 2016. Partnership required for Phase 3 development.
MPC-300-IV
Rheumatoid arthritis
Noted April 10, 2017 that interim analysis has been completed - trial to continue as planned.
MPC-150-IM
Chronic heart failure (CHF)